Mod GRF 1-29 vs CJC-1295: How They Differ, and Where Sermorelin Fits

Peptide science sketches framing the article title

Mod GRF 1-29 and “CJC-1295 without DAC” are two names for the same 29-amino-acid peptide. The real comparison is between that short-acting version and CJC-1295 with DAC, which carries an extra chemical group that keeps it in the body for days instead of hours. Sermorelin is the original, unmodified sequence that both were built from. This guide explains how the three differ, what human research does and does not show, and what Canadian rules mean for you.

Pure Peptide
purepeptide.co
Understand the Peptides Before You Choose
Explore Pure Peptide’s information on peptides for health and wellness, including compounds discussed in this guide.

Visit Pure Peptide

TL;DR

  • Mod GRF 1-29 and CJC-1295 no DAC are the same peptide. The label “CJC-1295” alone is ambiguous, so check whether DAC is included.
  • DAC links the peptide to albumin in the blood. In a 2006 human trial, that gave an estimated half-life of roughly 5.8 to 8.1 days, against minutes to hours for the no-DAC form.
  • Sermorelin is the native GHRH(1-29) sequence. Mod GRF 1-29 is its modified, more stable relative.
  • Human data show clear rises in growth hormone (GH) and IGF-1. Data on muscle, fat loss and recovery in healthy adults are thin.
  • In Canada, injectable peptides are regulated as prescription medications. Read the legal section before you act.

Table of Contents

Why the names cause so much confusion

Peptide listings use the names loosely. You will see “CJC-1295 no DAC”, “Mod GRF 1-29”, “Modified GRF (1-29)”, “tetrasubstituted GRF” and plain “CJC-1295” used for the same compound or for different ones. Searchers end up comparing two things that are identical, or comparing one name against a different compound without knowing it.

Here is the vocabulary in plain terms:

  • GHRH is growth hormone-releasing hormone, the signal your hypothalamus sends to the pituitary to release GH.
  • GHRH(1-29) is the first 29 amino acids of that hormone, the shortest stretch that keeps full activity. Sermorelin is this native sequence.
  • Mod GRF 1-29 is GHRH(1-29) with four amino acid substitutions. According to a summary of the compound, these sit at positions 2, 8, 15 and 27, and the position-2 change helps it resist the DPP-4 enzyme that normally chops up the native peptide.
  • CJC-1295 without DAC is that same four-substitution peptide under a different label. Our own guides cover it as CJC-1295 no DAC and CJC no DAC.
  • CJC-1295 with DAC adds a drug affinity complex (DAC) to the end of the chain. See our CJC-1295 DAC guide.

So the question “Mod GRF 1-29 or CJC-1295?” really means “no DAC or DAC?” The next section answers that.

Mod GRF 1-29 vs CJC-1295 with DAC

The academic description of CJC-1295 with DAC is a tetrasubstituted GHRH(1-29) core joined through a lysine to a maleimidopropionic acid group. That group binds to cysteine-34 on serum albumin, the most abundant protein in blood, according to the 2006 study in the Journal of Clinical Endocrinology and Metabolism. Riding on albumin protects the peptide from breakdown and kidney clearance, which is why its estimated half-life was 5.8 to 8.1 days.

Mod GRF 1-29 has no such anchor. It resists the first enzyme that breaks native GHRH down, but it is still cleared within hours. Its effect is a shorter pulse of GH release.

Feature Sermorelin Mod GRF 1-29 (CJC-1295 no DAC) CJC-1295 with DAC
What it is Native GHRH(1-29) GHRH(1-29) with four substitutions Same four substitutions plus DAC
Albumin binding No No Yes
Duration of action Short Short, somewhat longer than native Days (estimated half-life about 6 to 8 days)
Signal pattern Brief pulse Brief pulse Sustained, continuous elevation
Typical use pattern described in research Frequent, small doses Frequent, small doses Infrequent doses

The pattern matters more than the numbers. Your body releases GH in pulses, mostly during deep sleep. A short-acting analogue is meant to add to a pulse. A long-acting one raises the baseline for days. The 2006 trial recorded GH rising 2- to 10-fold for six days or more and IGF-1 rising 1.5- to 3-fold for 9 to 11 days after a single injection in healthy adults aged 21 to 61, and it reported no serious adverse reactions. That is a strong biomarker result. It is a measure of hormone levels, not of muscle, fat or recovery.

Why people choose no DAC

People who prefer Mod GRF 1-29 usually cite a closer match to the body’s own pulsing rhythm and finer control over timing, since the effect fades within hours. Community discussions often pair it with a growth hormone secretagogue such as ipamorelin, because the two act through different receptors. Treat those threads as opinion rather than evidence.

Why people choose DAC

The appeal is convenience and a steady signal. Fewer injections means less handling. The trade-off is that you cannot easily “turn it off” once it is in your system, which is why any use should be planned with a clinician. Our CJC-1295 peptide guide walks through both forms side by side.

Mod GRF 1-29 vs sermorelin

This is the other comparison readers search for, in either order. Both are GHRH analogues acting at the same pituitary receptor. The difference is stability.

Sermorelin is the native sequence. It is the simplest and has the longest history of clinical use as a diagnostic and treatment agent. Because it has no protection against DPP-4, it is cleared quickly, so the GH pulse it produces is brief.

Mod GRF 1-29 adds substitutions that make it more stable and, in the descriptions we have seen, somewhat longer-lasting and more potent per dose. It is still a short-acting compound, not a multi-day one. In practice:

  • Sermorelin: the original template, a brief pulse, and the form most often discussed in age-related GH decline.
  • Mod GRF 1-29: a more durable version of the same idea, still pulse-like.
  • Neither holds the multi-day action that DAC provides.

If you read a product page claiming exact half-lives for sermorelin or Mod GRF 1-29 in minutes, treat it as indicative. Precise human pharmacokinetic figures for these short-acting forms are far less documented than the DAC trial above. Our sermorelin benefits article covers what its research reports on IGF-1 and sleep.

What the human evidence supports

All three peptides raise GH and, downstream, IGF-1. That part is well established, and the DAC trial is the clearest example.

What is not established is the leap from higher hormone numbers to better body composition or performance in healthy people. Reviews of the CJC-1295 literature point out that most trials measured hormonal biomarkers rather than functional outcomes, and that long-term human outcome data are lacking. Higher GH and IGF-1 do not automatically translate into clinical improvement.

That is a reason to set realistic goals, and to track what you care about:

  • Sleep quality, energy and recovery between sessions, using a simple weekly log.
  • Body composition measured the same way each time, such as the same scale, the same tape, the same time of day.
  • Bloodwork such as IGF-1, fasting glucose and lipids, ordered through your own physician.

Small, honest tracking tells you more than any forum thread. For a closer look at the claims, see our CJC-1295 benefits breakdown and our overview of peptides for growth hormone.

Canada: what the rules say

This is where readers in Canada need to slow down. According to the College of Physicians & Surgeons of Alberta, injectable peptides are regulated as prescription medications in Canada. Prescription medications can only be legally sold by licensed pharmacies, and authorized products carry a DIN, NPN or DIN-HM on the label. The same notice reports that Health Canada has issued several warnings about unauthorized injectable peptides and has seized products from multiple vendors.

A BC medical access guide states that GH peptides such as sermorelin and CJC-1295 do not hold a DIN in Canada and are classed as unauthorized drugs by Health Canada as of April 2026. It adds that a “research use only” label does not change that status.

What this means in practice:

  • Read the label and our legality guide before you decide anything. It explains the DIN question in detail.
  • Do not treat a product as a medication for human use on the strength of its marketing.
  • Talk to a physician or pharmacist about GH-related goals. They can order tests, discuss authorized options and tell you what suits your health history.

The CPSA also warns that unauthorized or counterfeit injectables may contain undisclosed ingredients, additives or contaminants, and can cause infections or allergic reactions. That is why purity documentation and sterile handling matter to us. Our certificate of analysis page shows the third-party lab documentation behind our products, and our peptide safety guide covers handling.

Warning signs and when to get medical help

Any injectable can cause reactions. Watch for redness, swelling or warmth spreading from the injection site, fever, hives, facial swelling, trouble breathing, or a rapid heartbeat. Hives, facial swelling or trouble breathing need emergency care: call 911. Spreading redness, fever or a lump that grows or becomes painful should be seen by a doctor or at urgent care the same day. For ongoing symptoms such as persistent headaches, joint pain, numbness or swelling in the hands, book a visit with your family doctor and bring a list of everything you take.

Mild redness visible on a forearm in a clinic

How to choose between them

Start from what you are trying to understand, not from the product name.

  1. You want the shortest, most pulse-like signal: the no-DAC family, meaning sermorelin or Mod GRF 1-29, matches that profile.
  2. You want the most durable, simplest-to-schedule signal: DAC is the form with documented multi-day action.
  3. You want the original template with the longest clinical history: sermorelin.
  4. You are unsure: begin with a conversation with a physician about your goals and baseline labs.

Whatever you pick, check three things on the listing: that it states clearly whether DAC is included, that it provides a batch-specific certificate of analysis, and that it includes the ancillaries needed for clean handling, such as bacteriostatic water, syringes and alcohol pads.

Perspective

Most of the confusion in this category comes from naming. When someone searches for CJC-1295 and finds Mod GRF 1-29 sold under that name, they deserve to know exactly what is in the vial and what it does.

We believe the buyer’s best protection is clarity. That is why we label whether DAC is present, why our products are supported by third-party lab certificates of analysis, and why we aim for purity above 99% through advanced purification methods.

We also believe in realistic expectations. These peptides are well studied for their effect on GH and IGF-1 signalling, and our customers come to us for specific goals such as recovery, body composition and healthy ageing. We write our guides to help you match the right compound to the right goal, and to handle it safely.

Canadian rules around injectable peptides are specific, and we encourage every customer to read them and to involve a physician.

Pure Peptide

Where to find what we offer

If you have decided which form fits your goal, you can browse our growth hormone peptide range, our recovery peptides and the reconstitution ancillaries on our main site. Each product page carries its certificate of analysis. For a wider look at compliance in Canada, read our guide to buying peptides in Canada.

FAQ

Is Mod GRF 1-29 the same as CJC-1295?

Mod GRF 1-29 is the same compound as CJC-1295 without DAC. It is not the same as CJC-1295 with DAC, which has an added group that binds albumin and extends action to days. Always check whether a listing says “with DAC” or “no DAC”.

Is Mod GRF 1-29 better than sermorelin?

They are not ranked on one scale. Mod GRF 1-29 is a modified, more stable form of the sermorelin sequence, and both produce short pulses of GH release. Sermorelin has the longer clinical history. The choice depends on your goal and what a physician advises.

Do these peptides build muscle or burn fat?

They raise GH and IGF-1, and the DAC trial showed this clearly in healthy adults. Direct human evidence for muscle growth or fat loss in healthy people is limited, because most studies measured hormone levels rather than physical outcomes. Tracking your own measures and bloodwork gives a more useful answer.

Injectable peptides are regulated as prescription medications, and sermorelin and CJC-1295 do not hold a DIN in Canada. A research use label does not change their legal status. Our legality guide explains the details, and a pharmacist or physician can advise on authorized options.

Which warning signs mean I should see a doctor?

Spreading redness, fever, hives, facial swelling or a growing painful lump at the injection site need prompt medical attention. Trouble breathing or facial swelling calls for 911. Persistent symptoms such as headaches or joint pain are worth a visit with your family doctor.

Sources